Exposure of implanted urethral bulking agent into urethra Save
ICD-10 code: T83.723
Chapter: Injury, poisoning and certain other consequences of external causes
Exposure of implanted urethral bulking agent into urethra
Urethral bulking agents are used to treat urinary incontinence in women. They are injected into the urethra to increase its thickness and reduce urinary leakage. While the procedure is generally safe, there is a risk of exposure of the implanted agent into the urethra.
- Cause of Exposure: Exposure of the bulking agent can occur due to a variety of reasons, including migration of the agent from the injection site, erosion of the surrounding tissue, or the use of an inappropriate agent.
- Symptoms: The symptoms of exposure of the bulking agent into the urethra may include pain or discomfort during urination, blood in the urine, or recurrent urinary tract infections.
- Treatment: Treatment for exposure of the implanted urethral bulking agent into the urethra may include removal of the agent, antibiotics to treat any infection, or surgery to repair any tissue damage.
It is important to note that exposure of the implanted bulking agent into the urethra is a rare complication. The risk can be minimized by choosing a qualified and experienced surgeon, using appropriate agents, and following post-operative care instructions carefully.
If you experience any symptoms of exposure of the implanted bulking agent into the urethra, it is important to contact your healthcare provider immediately. Early intervention can prevent further complications and ensure a successful outcome.